JINLING PHARMACEUTICAL COMPANY LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.96 CNY | +1.90% |
|
+8.75% | -11.56% |
| Sales 2022 | 2.67B 369M 29.44B | Sales 2023 | 2.79B 385M 30.71B | Capitalization | 4.02B 556M 44.34B |
|---|---|---|---|---|---|
| Net income 2022 | 105M 14.5M 1.16B | Net income 2023 | 99M 13.67M 1.09B | EV / Sales 2022 | 0.8 x |
| Net cash position 2022 | 1.83B 253M 20.19B | Net cash position 2023 | 1.51B 208M 16.62B | EV / Sales 2023 | 0.9 x |
| P/E ratio 2022 |
37.2
x | P/E ratio 2023 |
39.8
x | Employees | 4,880 |
| Yield 2022 |
1.29% | Yield 2023 |
-
| Free-Float | 54.06% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.90% | ||
| 1 week | +8.75% | ||
| Current month | +1.90% | ||
| 1 month | +1.90% | ||
| 3 months | -3.33% | ||
| 6 months | -14.39% | ||
| Current year | -11.56% |
1 week
6.38
6.99
1 month
6.187.05
Current year
5.388.24
1 year
5.3810.13
3 years
5.3812.00
5 years
5.3812.00
10 years
5.3830.47
| Managers | Title | Age | Since |
|---|---|---|---|
Sheng Chen
CHM | Chairman | 55 | 27/06/17 |
Guang Yu Yan
BRD | Director/Board Member | 46 | 31/07/19 |
Yang Wang
BRD | Director/Board Member | 46 | 31/12/05 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yang Wang
BRD | Director/Board Member | 46 | 31/12/05 |
Yong Jian Shen
BRD | Director/Board Member | 46 | 21/06/20 |
Sheng Chen
CHM | Chairman | 55 | 27/06/17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.04% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 6.96 | +1.90% | 9,502,681 |
| 29/04/24 | 6.83 | +3.17% | 6,342,218 |
| 26/04/24 | 6.62 | +0.15% | 4,230,501 |
| 25/04/24 | 6.61 | +1.54% | 4,920,222 |
| 24/04/24 | 6.51 | +1.56% | 4,072,802 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
Jinling Pharmaceutical Company Limited is a China-based company principally engaged in the manufacture and sale of traditional Chinese medicines and chemical drugs. The Companyâs main products include Mailuoning injections, ferrous succinate tablets and Lentinan injection, among others. The Company is also involved in the provision of medical services and the sale of medical instrument. The Company distributes its products in domestic market, with North China as its main market.
Sector
Pharmaceuticals
Calendar
26/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -11.56% | 605M | |
| +29.68% | 699B | |
| +25.07% | 571B | |
| -4.35% | 364B | |
| +17.65% | 326B | |
| +3.77% | 286B | |
| +14.68% | 236B | |
| +4.71% | 198B | |
| -12.43% | 194B | |
| -3.79% | 154B |
- Stock Market
- Equities
- 000919 Stock
